or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    CNTA D Centessa Pharmaceuticals plc -5.60
    PBYI D Puma Biotechnology Inc 1.04
    PYXS D Pyxis Oncology, Inc. -3.37
    CCCC D C4 Therapeutics, Inc. -3.55
    LCTX F Lineage Cell Therapeutics, Inc. 0.91
    AVBP F ArriVent BioPharma, Inc. 1.57
    PPBT F Purple Biotech Ltd. 0.64
    BCAB F BioAtla, Inc. -4.26
    AGEN F Agenus Inc. 11.86
    NXTC F NextCure, Inc. -10.42
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Biopharmaceutical Medicine Solid Tumors Immunotherapy Melanoma Small Cell Lung Cancer Biotechnology Cancer Immunotherapy Cancer Treatment Drugs Immunotherapies Multiple Myeloma Ovarian Cancer Synovial Sarcoma Virotherapy Acute Myeloid Leukemia Antibody Drug Conjugate Cervical Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.15
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.68
    GERM F ETFMG Treatments Testing and Advancements ETF 2.55
    XHS C SPDR S&P Health Care Services ETF 1.39
    SBIO D ALPS Medical Breakthroughs ETF 0.59
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare CNCR to GERM Compare CNCR to XHS Compare XHS to SBIO

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Apr 25 PPBT Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
        Apr 24 BCAB BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 NXTC NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
        Apr 24 CNTA Centessa: Hemophilia B Data Readout In 2024 Is Major Turning Point
        Apr 24 AGEN Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
        Apr 24 CNTA Centessa Pharmaceuticals prices $100M ADS offering
        Apr 24 CNTA Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
        Apr 23 CNTA Centessa Pharmaceuticals announces $100M proposed public offering of American Depositary Shares
        Apr 23 CNTA Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
        Apr 23 AGEN Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month
        Apr 23 AGEN Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
        Apr 22 AVBP ArriVent Appoints Kristine Peterson to its Board of Directors
        Apr 22 CNTA Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
        Apr 22 AGEN Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
        Apr 19 LCTX 12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Medicine Solid Tumors Biopharmaceutical Cancer Immunotherapy Clinical Medicine Melanoma Multiple Myeloma Prostate Cancer Antibodies Biotechnology Breast Cancer Cell Therapy Clinical Trial Drug Discovery Hematological Cancers Immune System Immunology Immunotherapy
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags